Identification and Characterization of Functional Human Monoclonal Antibodies to Plasmodium vivax Duffy-Binding Protein

scientific article published on 03 April 2019

Identification and Characterization of Functional Human Monoclonal Antibodies to Plasmodium vivax Duffy-Binding Protein is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.4049/JIMMUNOL.1801631
P932PMC publication ID6764764
P698PubMed publication ID30944159

P50authorJean PopoviciQ54438232
Marcelo U. FerreiraQ55033395
Sebastien DechavanneQ61099536
Samantha J BarnesQ89705262
Edwin ChenQ92827820
Seila SuonQ114064044
Sokunthea SrengQ114064053
Chanaki AmaratungaQ28035108
John H. AdamsQ47150509
P2093author name stringNiraj H Tolia
Benoit Witkowski
Rick M Fairhurst
Christopher L King
Lenore L Carias
Camille Roesch
Vanessa C Nicolete
Celia Dechavanne
P2860cites workA public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein.Q53700367
A comprehensive model for assessment of liver stage therapies targeting Plasmodium vivax and Plasmodium falciparum.Q54216698
Antihomotypic affinity maturation improves human B cell responses against a repetitive epitopeQ56376231
Genetic diversity in two Plasmodium vivax protein ligands for reticulocyte invasionQ57805338
The sequence manipulation suite: JavaScript programs for analyzing and formatting protein and DNA sequencesQ73927391
IMGT/V-QUEST: IMGT standardized analysis of the immunoglobulin (IG) and T cell receptor (TR) nucleotide sequencesQ84245408
Red blood cell invasion by Plasmodium vivax: structural basis for DBP engagement of DARCQ21131367
The Resistance Factor to Plasmodium vivax in BlacksQ22250916
Plasmodium vivax clinical malaria is commonly observed in Duffy-negative Malagasy peopleQ24600330
Changes in malaria burden and transmission in sentinel sites after the roll-out of long-lasting insecticidal nets in Papua New GuineaQ26315315
The Duffy binding protein as a key target for a Plasmodium vivax vaccine: lessons from the Brazilian AmazonQ27009149
Broadly neutralizing antibodies against influenza virus and prospects for universal therapiesQ27010503
Development of a humanized monoclonal antibody with therapeutic potential against West Nile virusQ27473186
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 DonorsQ27643993
Dimerization of Plasmodium vivax DBP is induced upon receptor binding and drives recognition of DARCQ27670749
Plasmodium vivax vaccine research - we've only just begunQ28079136
The Presence, Persistence and Functional Properties of Plasmodium vivax Duffy Binding Protein II Antibodies Are Influenced by HLA Class II Allelic VariantsQ28396379
Plasmodium vivax invasion of human erythrocytes inhibited by antibodies directed against the Duffy binding proteinQ28471832
Structural analysis of the synthetic Duffy Binding Protein (DBP) antigen DEKnull relevant for Plasmodium vivax malaria vaccine designQ28544738
Global Epidemiology of Plasmodium vivaxQ30249044
Isolation of a monoclonal antibody from a malaria patient-derived phage display library recognising the Block 2 region of Plasmodium falciparum merozoite surface protein-1.Q30651257
Recombinant human antibodies specific for the Pfs48/45 protein of the malaria parasite Plasmodium falciparumQ30984883
A family of erythrocyte binding proteins of malaria parasitesQ33198214
Human recombinant antibodies against Plasmodium falciparum merozoite surface protein 3 cloned from peripheral blood leukocytes of individuals with immunity to malaria demonstrate antiparasitic propertiesQ33244194
Production of high-affinity human monoclonal antibody fab fragments to the 19-kilodalton C-terminal merozoite surface protein 1 of Plasmodium falciparumQ33282524
Single-chain antibody fragment specific for Plasmodium vivax Duffy binding proteinQ33282823
Differential patterns of infection and disease with P. falciparum and P. vivax in young Papua New Guinean childrenQ33530114
Human vaccination against Plasmodium vivax Duffy-binding protein induces strain-transcending antibodies.Q33798074
Fy(a)/Fy(b) antigen polymorphism in human erythrocyte Duffy antigen affects susceptibility to Plasmodium vivax malariaQ34236565
Characterization of inhibitory anti-Duffy binding protein II immunity: approach to Plasmodium vivax vaccine development in ThailandQ34256740
Immunogenicity of a synthetic vaccine based on Plasmodium vivax Duffy binding protein region II.Q34260750
Identification of the erythrocyte binding domains of Plasmodium vivax and Plasmodium knowlesi proteins involved in erythrocyte invasionQ34331219
HIV-1 therapy with monoclonal antibody 3BNC117 elicits host immune responses against HIV-1.Q34527469
HIV-1 antibody 3BNC117 suppresses viral rebound in humans during treatment interruptionQ34531858
Natural variation within the principal adhesion domain of the Plasmodium vivax duffy binding proteinQ34548865
The most polymorphic residue on Plasmodium falciparum apical membrane antigen 1 determines binding of an invasion-inhibitory antibodyQ34601904
Ex vivo characterization and isolation of rare memory B cells with antigen tetramersQ35112237
Submicroscopic and asymptomatic Plasmodium falciparum and Plasmodium vivax infections are common in western Thailand - molecular and serological evidenceQ35128307
Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection CohortQ35894094
Biosignatures of Exposure/Transmission and ImmunityQ36071335
Independent Origin and Global Distribution of Distinct Plasmodium vivax Duffy Binding Protein Gene DuplicationsQ36178527
Mechanism of Binding to Ebola Virus Glycoprotein by the ZMapp, ZMAb, and MB-003 Cocktail AntibodiesQ36208191
The domain on the Duffy blood group antigen for binding Plasmodium vivax and P. knowlesi malarial parasites to erythrocytesQ36367429
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloningQ36459907
Towards HIV-1 remission: potential roles for broadly neutralizing antibodiesQ36515149
Naturally acquired Duffy-binding protein-specific binding inhibitory antibodies confer protection from blood-stage Plasmodium vivax infectionQ36751523
Higher microsatellite diversity in Plasmodium vivax than in sympatric Plasmodium falciparum populations in Pursat, Western CambodiaQ36952727
Broadly neutralizing epitopes in the Plasmodium vivax vaccine candidate Duffy Binding ProteinQ36978206
Strain-specific duffy binding protein antibodies correlate with protection against infection with homologous compared to heterologous plasmodium vivax strains in Papua New Guinean childrenQ37333369
Human pregnancy-associated malaria-specific B cells target polymorphic, conformational epitopes in VAR2CSAQ37426131
Characterization of a novel inhibitory human monoclonal antibody directed against Plasmodium falciparum Apical Membrane Antigen 1.Q37522507
Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeastQ37643896
Prevention of Respiratory Syncytial Virus Infection: From Vaccine to AntibodyQ38535730
Expression cloning of human B cell immunoglobulinsQ39214732
The Immunoregulatory Roles of Antibody GlycosylationQ39225081
Epitope-specific humoral immunity to Plasmodium vivax Duffy binding protein.Q39746136
Improved light microscopy counting method for accurately counting Plasmodium parasitemia and reticulocytemiaQ40716448
Isolation, production and characterization of fully human monoclonal antibodies directed to Plasmodium falciparum MSP10.Q41587442
Antibody-specific model of amino acid substitution for immunological inferences from alignments of antibody sequencesQ41657201
Strain-transcending Fc-dependent killing of Plasmodium falciparum by merozoite surface protein 2 allele-specific human antibodiesQ42102268
Atypical and classical memory B cells produce Plasmodium falciparum neutralizing antibodies.Q43245288
Naturally Acquired Binding-Inhibitory Antibodies to Plasmodium vivax Duffy Binding Protein and Clinical Immunity to Malaria in Rural Amazonians.Q46926980
An engineered vaccine of the Plasmodium vivax Duffy binding protein enhances induction of broadly neutralizing antibodiesQ47150417
Structural basis for antibody recognition of the NANP repeats in Plasmodium falciparum circumsporozoite proteinQ47161602
Transferrin receptor 1 is a reticulocyte-specific receptor for Plasmodium vivax.Q47208042
Tracking human antigen-specific memory B cells: a sensitive and generalized ELISPOT systemQ47756393
Rationale for development of a synthetic vaccine against plasmodium falciparum malariaQ47886490
Enhanced ex vivo Plasmodium vivax intraerythrocytic enrichment and maturation for rapid and sensitive parasite growth assaysQ48023790
Clonal selection drives protective memory B cell responses in controlled human malaria infectionQ49913937
A human monoclonal antibody prevents malaria infection by targeting a new site of vulnerability on the parasite.Q52350559
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectPlasmodium vivaxQ311376
P304page(s)2648-2660
P577publication date2019-04-03
P1433published inJournal of ImmunologyQ3521441
P1476titleIdentification and Characterization of Functional Human Monoclonal Antibodies to Plasmodium vivax Duffy-Binding Protein
P478volume202